STOCK TITAN

[SCHEDULE 13G/A] Pliant Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:07/29/2025
Pliant Therapeutics, Inc.

NASDAQ:PLRX

PLRX Rankings

PLRX Latest News

PLRX Latest SEC Filings

PLRX Stock Data

91.47M
59.50M
3.04%
85.7%
5.47%
Biotechnology
Pharmaceutical Preparations
Link
United States
SOUTH SAN FRANCISCO